Evidence map›Paper›PMID 23384127›Full record

ArticleCell communication and signaling : CCS2013

Altered responsiveness to extracellular ATP enhances acetaminophen hepatotoxicity.

Sylvia S Amaral, André G Oliveira, Pedro E Marques, Jayane L D Quintão, Daniele A Pires, Rodrigo R Resende, Bruna R Sousa, Juliana G Melgaço, Marcelo A Pinto, Remo C Russo and 11 more

Open access · goldAbstract read
In one paragraph

Article in Cell communication and signaling : CCS, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
7.8field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 55 citations in OpenAlex.

  1. Purinergic Signaling in Non-Parenchymal Liver Cells.International journal of molecular sciences · 2024
    Review
  2. Article
  3. ATP functions as a primary alarmin in allergen-induced type 2 immunity.American journal of physiology. Cell physiology · 2023
    Review
  4. Review
  5. Review
  6. Customizable Microfluidic Origami Liver-on-a-Chip (oLOC).Advanced materials technologies · 2022
    Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Time serial transcriptome revealsCancer biology & medicine · 2020
    Article
  12. Article
  13. Purinergic signaling in hepatic disease.Purinergic signalling · 2019
    Review
  14. Review
  15. Article
  16. Review
  17. Review
  18. Article
  19. IL-33 signalling in liver immune cells enhances drug-induced liver injury and inflammation.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2018
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 4 institutions in 2 countries.

Sylvia S AmaralLaboratório de Imunobiofotônica, Departamento de Morfologia, UFMG, Belo Horizonte, MG, Brazil. menezesgb@gmail.com.
André G Oliveira
Pedro E Marques
Jayane L D Quintão
Daniele A Pires
Rodrigo R Resende
Bruna R Sousa
Juliana G Melgaço
Marcelo A Pinto
Remo C Russo
Ariane K C Gomes
Lidia M Andrade
Rafael F Zanin
Rafaela V S Pereira
Cristina Bonorino
Frederico M Soriani
Cristiano X Lima
Denise C Cara
Mauro M Teixeira
Maria F Leite
Gustavo B Menezes
Universidade Federal de Minas Gerais · BRFundação Oswaldo Cruz · BRPontifícia Universidade Católica do Rio Grande do Sul · BRHoward Hughes Medical Institute · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAdenosine triphosphate (ATP) is secreted from hepatocytes under physiological conditions and plays an important role in liver biology through the activation of P2 receptors. Conversely, higher extracellular ATP concentrations, as observed during necrosis, trigger inflammatory responses that contribute to the progression of liver injury. Impaired calcium (Ca2+) homeostasis is a hallmark of acetaminophen (APAP)-induced hepatotoxicity, and since ATP induces mobilization of the intracellular Ca2+ stocks, we evaluated if the release of ATP during APAP-induced necrosis could directly contribute to hepatocyte death.

resultsAPAP overdose resulted in liver necrosis, massive neutrophil infiltration and large non-perfused areas, as well as remote lung inflammation. In the liver, these effects were significantly abrogated after ATP metabolism by apyrase or P2X receptors blockage, but none of the treatments prevented remote lung inflammation, suggesting a confined local contribution of purinergic signaling into liver environment. In vitro, APAP administration to primary mouse hepatocytes and also HepG2 cells caused cell death in a dose-dependent manner. Interestingly, exposure of HepG2 cells to APAP elicited significant release of ATP to the supernatant in levels that were high enough to promote direct cytotoxicity to healthy primary hepatocytes or HepG2 cells. In agreement to our in vivo results, apyrase treatment or blockage of P2 receptors reduced APAP cytotoxicity. Likewise, ATP exposure caused significant higher intracellular Ca2+ signal in APAP-treated primary hepatocytes, which was reproduced in HepG2 cells. Quantitative real time PCR showed that APAP-challenged HepG2 cells expressed higher levels of several purinergic receptors, which may explain the hypersensitivity to extracellular ATP. This phenotype was confirmed in humans analyzing liver biopsies from patients diagnosed with acute hepatic failure.

conclusionWe suggest that under pathological conditions, ATP may act not only an immune system activator, but also as a paracrine direct cytotoxic DAMP through the dysregulation of Ca2+ homeostasis.

Identifiers

PMID23384127
PMCPMC3608937
OpenAlexW2114888865

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.